Nano Holdings Inc. (4571.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Nano Holdings Inc.
Address
2-5-1 Atago, Atago Green Hills Mori Tower 26F
Minato, 105-6226
Japan
Phone
81 3 3241 0550
Website
Sector
Healthcare
Industry
Biotechnology
Employees
23
First IPO Date
March 05, 2008
Key Executives
| Name | Title | Pay | Year Born |
| Shiro Akinaga | President, Chief Executive Officer & Representative Director | 0 | 1956 |
| Koji Fujimoto | Executive Officer & Chief Financial Officer | 0 | 1972 |
| Satoru Iino | Director & Chief Investment Officer | 0 | 1965 |
Description
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.
